| FoxM1 repression during human aging leads to mitotic decline and aneuploidy-driven full senescence JC Macedo, S Vaz, B Bakker, R Ribeiro, PL Bakker, JM Escandell, ... Nature communications 9 (1), 2834, 2018 | 113 | 2018 |
| The FOXM1 inhibitor RCM-1 decreases carcinogenesis and nuclear β-catenin S Shukla, D Milewski, A Pradhan, N Rama, K Rice, T Le, MJ Flick, S Vaz, ... Molecular cancer therapeutics 18 (7), 1217-1229, 2019 | 39 | 2019 |
| Mitotic dysfunction associated with aging hallmarks JC Macedo, S Vaz, E Logarinho Cell Division Machinery and Disease, 153-188, 2017 | 37 | 2017 |
| Candidate Alzheimer’s disease biomarker miR-483-5p lowers TAU phosphorylation by direct ERK1/2 repression S Nagaraj, A Want, K Laskowska-Kaszub, A Fesiuk, S Vaz, E Logarinho, ... International journal of molecular sciences 22 (7), 3653, 2021 | 22 | 2021 |
| The antitumor efficacy of monomeric disintegrin obtustatin in S-180 sarcoma mouse model N Ghazaryan, N Movsisyan, JC Macedo, S Vaz, N Ayvazyan, L Pardo, ... Investigational new drugs 37, 1044-1051, 2019 | 13 | 2019 |
| FOXM1 repression increases mitotic death upon antimitotic chemotherapy through BMF upregulation S Vaz, FJ Ferreira, JC Macedo, G Leor, U Ben-David, J Bessa, ... Cell Death & Disease 12 (6), 542, 2021 | 11 | 2021 |
